EVP, R&D
Tue, Jun 2, 2026
Jun 2
3,907 shares @ $168.54
Decreased holdings by -18.20%
Net across this filing: 0.00% (+0 shares)
9th largest trade (out of 94)
Planned (10b5-1)
“This transaction was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on February 27, 2026.”Form 4 footnote
Trade made by an officer
Executed under a pre-scheduled Rule 10b5-1 plan
Net holdings across this filing: +0.0% (+0 shares)
0% win rate · -7.3% median edge vs SPY (5 trades, 90-day · small sample)
Price 27% above 200-day moving average
Win rate excludes trades classified as routine (tax, 10b5-1, exercise, gift).